11th May 2015 06:58
LONDON (Alliance News) - NetScientific PLC Monday said François Martelet will join the company on June 8 as its new chief executive with Executive Chairman Richard Sykes reverting to the non-executive chairman role.
Most recently, Martelet served as senior advisor to the CEO at Stallergenes SA, where he was responsible for international commercial strategies. Before this, he was CEO at European biotech company Topotarget A/S, and CEO of Avax Technologies Inc, a US biotech company specialised in therapeutic oncology vaccines.
"Dr. Martelet further strengthens NetScientific's management team at a time when a number of the group's portfolio companies will soon be entering commercialisation. He brings over 20 years of biopharma experience and a proven track record of shaping and developing businesses to deliver returns. With his broad experience in both large and small companies, deep knowledge of commercialisation and his proven managerial capability, François will be a great asset to the business in growing its innovative technology portfolio," Sykes said.
By Steve McGrath; [email protected]; @stevemcgrath1
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Netscientific